Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

The efficacy of neoadjuvant therapy (NT) versus surgery first (SF) for pancreatic ductal adenocarcinoma (PDAC) remains controversial. A random-effects meta-analysis of only prospective randomized controlled trials (RCTs) comparing NT versus SF for potentially resectable (PR) or borderline resectable...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Med
Main Authors: Cloyd, Jordan M., Heh, Victor, Pawlik, Timothy M., Ejaz, Aslam, Dillhoff, Mary, Tsung, Allan, Williams, Terence, Abushahin, Laith, Bridges, John F. P., Santry, Heena
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231310/
https://ncbi.nlm.nih.gov/pubmed/32326559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041129
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki